| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $565.7M | +13.4% |
| Cost of Revenue | $309.3M | +13.0% |
| Gross Profit | $256.3M | +13.9% |
| R&D Expense | $130.1M | +11.2% |
| SG&A Expense | $90.2M | +15.7% |
| Operating Income | -$104.8M | -34.3% |
| Pre-tax Income | -$106.1M | +4.5% |
| Income Tax | $2.9M | +77.0% |
| Net Income | -$109.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $199.6M | -38.2% |
| Short-term Investments | $233.8M | +122.9% |
| Accounts Receivable | $46.7M | -0.5% |
| Current Assets | $531.1M | +1.7% |
| Total Assets | $1.35B | -2.6% |
| Current Liabilities | $192.0M | +14.1% |
| Total Liabilities | $930.7M | +14.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $36.6M | +18.2% |
| Capital Expenditures | $11.1M | -43.6% |
| Investing Cash Flow | -$165.6M | -154.2% |
| Financing Cash Flow | $5.9M | +111.5% |
| Free Cash Flow | $25.4M | +127.5% |
| +3.3% |
| EPS (Basic) | -$1.90 | +5.0% |
| EPS (Diluted) | -$1.90 | +5.0% |
| Stockholders' Equity |
| $419.0M |
| -26.5% |